Theranos was once a Silicon Valley golden child, expanding rapidly, partnering with a major pharmacy, and raising over a billion dollars in funding.

But all of that came crashing down after a series of explosive reports, starting in 2015, by The Wall Street Journal reporter John Carreyrou called into question the efficacy of Theranos’ technology. The company claimed its technology could run blood tests with just a prick of a finger, but it was later revealed that Theranos used traditional blood testing machines for the majority of its tests, and that its own technology could produce inaccurate test results. READ MORE